NEJM:鳞翅目昆虫咬伤致荨麻疹案例报道

2015-10-29 chenshuo 译 MedSci原创

女性,42岁,近日因被一条三色的毛虫咬伤后中毒,而求助于美国亚利桑那州毒物和药物信息中心(AZPDIC)。据该女士称,她当时在院子里牧豆树底下,突然一条毛毛虫落到她的后左肩膀上。随后几分钟内,她的肩膀便开始出现瘙痒性的荨麻疹症状。1小时后,因症状的继续加重,该女士随即带着刚开始出现荨麻疹时所拍下的照片(如图A)和一条在院子里找到的相似的毛虫(如图B)来到了美国亚利桑那州毒物和药物信息中心(AZPD

女性,42岁,近日因被一条三色的毛虫咬伤后中毒,而求助于美国亚利桑那州毒物和药物信息中心(AZPDIC)。




据该女士称,她当时在院子里牧豆树底下,突然一条毛毛虫落到她的后左肩膀上。随后几分钟内,她的肩膀便开始出现瘙痒性的荨麻疹症状。

1小时后,因症状的继续加重,该女士随即带着刚开始出现荨麻疹时所拍下的照片(如图A)和一条在院子里找到的相似的毛虫(如图B)来到了美国亚利桑那州毒物和药物信息中心(AZPDIC),以求得到帮助。

工作人员建议她使用冷敷和外用抗组胺药霜来缓解她的症状。几天后,该女士肩膀上的麻疹症状便好转了很多。

Erucism(也叫毛毛虫皮炎)是由蛾或蝴蝶(鳞翅目类)的幼虫或蛹的阶段所产生的毒素导致的。在美国和世界各地有多个有毒的物种,其中在温带和热带气候区最为集中。

一般情况下,皮疹是Erucism最常见的临床表现和症状,通常发病是都采用抗组胺药和外用糖皮质激素治疗。但是,也有人曾经描述过,当这些毛毛虫身上脱离的毛随风进入到人的眼睛或被人吸入呼吸道时,也会产生严重的过敏性结膜炎或支气管痉挛等症状。

原始出处:

Robert N.E. French,Daniel Brillhart.Erucism Due to Lepidoptera Caterpillar Envenomation.N Engl J Med.October 29, 2015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1775819, encodeId=d4951e758199d, content=<a href='/topic/show?id=40bf59593a3' target=_blank style='color:#2F92EE;'>#昆虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59593, encryptionId=40bf59593a3, topicName=昆虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184738824945, createdName=zhanfl, createdTime=Sun Dec 27 12:14:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355555, encodeId=cf001355555c1, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 31 04:14:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585914, encodeId=29c8158591413, content=<a href='/topic/show?id=440039e9648' target=_blank style='color:#2F92EE;'>#咬伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39796, encryptionId=440039e9648, topicName=咬伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456317335577, createdName=habb, createdTime=Sat Oct 31 04:14:00 CST 2015, time=2015-10-31, status=1, ipAttribution=)]
    2015-12-27 zhanfl
  2. [GetPortalCommentsPageByObjectIdResponse(id=1775819, encodeId=d4951e758199d, content=<a href='/topic/show?id=40bf59593a3' target=_blank style='color:#2F92EE;'>#昆虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59593, encryptionId=40bf59593a3, topicName=昆虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184738824945, createdName=zhanfl, createdTime=Sun Dec 27 12:14:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355555, encodeId=cf001355555c1, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 31 04:14:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585914, encodeId=29c8158591413, content=<a href='/topic/show?id=440039e9648' target=_blank style='color:#2F92EE;'>#咬伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39796, encryptionId=440039e9648, topicName=咬伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456317335577, createdName=habb, createdTime=Sat Oct 31 04:14:00 CST 2015, time=2015-10-31, status=1, ipAttribution=)]
    2015-10-31 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1775819, encodeId=d4951e758199d, content=<a href='/topic/show?id=40bf59593a3' target=_blank style='color:#2F92EE;'>#昆虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59593, encryptionId=40bf59593a3, topicName=昆虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184738824945, createdName=zhanfl, createdTime=Sun Dec 27 12:14:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355555, encodeId=cf001355555c1, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 31 04:14:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585914, encodeId=29c8158591413, content=<a href='/topic/show?id=440039e9648' target=_blank style='color:#2F92EE;'>#咬伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39796, encryptionId=440039e9648, topicName=咬伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456317335577, createdName=habb, createdTime=Sat Oct 31 04:14:00 CST 2015, time=2015-10-31, status=1, ipAttribution=)]
    2015-10-31 habb

相关资讯

FDA批准奥马珠单抗(Xolair)用于慢性特发性荨麻疹

• 近50%的CIU患者在使用获批剂量的H1-抗组胺药治疗后疗效不佳,对于此类患者Xolair®是目前第一个且唯一一个获美国批准的治疗药物 • CIU在美国以外的地区被称为CSU,这是一种严重的皮肤病,特征表现为慢性瘙痒,荨麻疹和血管性水肿。 • Xolair®获得美国食品药品管理局批准用于治疗CIU的治疗严格依照欧盟批准Xolair®用于CSU的治疗准则

NEJM:奥玛珠单抗可有效治疗慢性特发性或自发性荨麻疹

许多慢性特发性荨麻疹(又称慢性自发性荨麻疹)患者对H1-抗组胺药治疗无应答,即便加大剂量仍然如此。在2期试验中,奥玛珠单抗,一种靶向IgE的IgE单克隆抗体能影响肥大细胞和嗜碱性粒细胞,且已显示对上述患者有效。德国柏林夏洛蒂医科大学皮肤病学和变态反应研究室的Maurer M博士等人对此进行了深入研究,他们发现,对于经许可剂量的H1-抗组胺药既往治疗但仍存在症状的慢性特发性荨麻疹患者,奥玛珠单抗可减